Breast MR-imaging of ductal carcinoma in situ: A systematic review

Imaging Decisions MRI

Volumn 13, Issue 3-4, 2009, Pages 112-121

  Schmitz, A C ^a   Smits, M L J ^a   Veldhuis, W ^a   Van Der Wall, E ^a   Van Hillegersberg, R ^a   Borel Rinkes, I H M ^a   Mali, W P Th M ^a   Van Den Bosch, M A A J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Breast; Ductal carcinoma in situ; Magnetic resonance imaging; Review

Indexed keywords

BREAST EXAMINATION; BREAST LESION; CANCER MORPHOLOGY; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; INTERMETHOD COMPARISON; INTRADUCTAL CARCINOMA; KINETICS; MAMMOGRAPHY; MORPHOLOGICAL TRAIT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TUMOR VOLUME;

EID: 77950514414     PISSN: 14333317     EISSN: 16170830     Source Type: Journal    
DOI: 10.1111/j.1617-0830.2010.01140.x     Document Type: Review

References (48)

1. Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002 359 : 909 919.
2. Leonard GD, Swain SM. Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst 2004 96 : 906 920.
3. Olivotto I, Levine M. Clinical practice guidelines for the care and treatment of breast cancer: the management of ductal carcinoma in situ (summary of the 2001 update). CMAJ 2001 165 : 912 913.
4. Recht A, Rutgers EJ, Fentiman IS, Kurtz JM, Mansel RE, Sloane JP. The fourth EORTC DCIS Consensus meeting. Eur J Cancer 1998 34 : 1664 1669.
5. Dershaw DD, Abramson A, Kinne DW. Ductal carcinoma in situ: mammographic findings and clinical implications. Radiology 1989 170 : 411 415.
6. Ikeda DM, Andersson I. Ductal carcinoma in situ: atypical mammographic appearances. Radiology 1989 172 : 661 666.
7. Stomper PC, Connolly JL, Meyer JE, Harris JR. Clinically occult ductal carcinoma in situ detected with mammography: analysis of 100 cases with radiologic-pathologic correlation. Radiology 1989 172 : 235 241.
8. Barreau B, de Mascarel I, Feuga C et al. Mammography of ductal carcinoma in situ of the breast: review of 909 cases with radiographic-pathologic correlations. Eur J Radiol 2005 54 : 55 61.
9. Holland R, Hendriks JH, Vebeek AL, Mravunac M, Schuurmans Stekhoven JH. Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 1990 335 : 519 522.
10. Peters NH, Borel RI, Zuithoff NP, Mali WP, Moons KG, Peeters PH. Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology 2008 246 : 116 124.
11. Schmitz AC, Peters NH, Veldhuis WB et al. Contrast-enhanced 3.0-T breast MRI for characterization of breast lesions: increased specificity by using vascular maps. Eur Radiol 2008 18 : 355 364.
12. Berg WA, Gutierrez L, NessAiver MS et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 2004 233 : 830 849.
13. Ernster VL, Ballard-Barbash R, Barlow WE et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 2002 94 : 1546 1554.
14. Boetes C, Strijk SP, Holland R, Barentsz JO, Van Der Sluis RF, Ruijs JH. False-negative MR imaging of malignant breast tumors. Eur Radiol 1997 7 : 1231 1234.
15. Orel SG, Mendonca MH, Reynolds C, Schnall MD, Solin LJ, Sullivan DC. MR imaging of ductal carcinoma in situ. Radiology 1997 202 : 413 420.
16. Kumar AS, Chen DF, Au A et al. Biologic significance of false-positive magnetic resonance imaging enhancement in the setting of ductal carcinoma in situ. Am J Surg 2006 192 : 520 524.
17. Hrung JM, Sonnad SS, Schwartz JS, Langlotz CP. Accuracy of MR imaging in the work-up of suspicious breast lesions: a diagnostic meta-analysis. Acad Radiol 1999 6 : 387 397.
18. ACR BI-RADS. Breast Imaging and Reporting Data System-Magnetic Resonance Imaging. American College of Radiology
19. Ikeda DM, Hylton NM, Kinkel K et al. Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies. J Magn Reson Imaging 2001 13 : 889 895.
20. Gilles R, Zafrani B, Guinebretiere JM et al. Ductal carcinoma in situ: MR imaging-histopathologic correlation. Radiology 1995 196 : 415 419.
21. Gilles R, Meunier M, Lucidarme O et al. Clustered breast microcalcifications: evaluation by dynamic contrast-enhanced subtraction MRI. J Comput Assist Tomogr 1996 20 : 9 14.
22. Westerhof JP, Fischer U, Moritz JD, Oestmann JW. MR imaging of mammographically detected clustered microcalcifications: is there any value? Radiology 1998 207 : 675 681.
23. Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 1999 213 : 881 888.
24. Nunes LW, Schnall MD, Orel SG. Update of breast MR imaging architectural interpretation model. Radiology 2001 219 : 484 494.
25. Heywang-Kobrunner SH, Bick U, Bradley WG Jr. et al. International investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions. Eur Radiol 2001 11 : 531 546.
26. Neubauer H, Li M, Kuehne-Heid R, Schneider A, Kaiser WA. High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement. Br J Radiol 2003 76 : 3 12.
27. Bluemke DA, Gatsonis CA, Chen MH et al. Magnetic resonance imaging of the breast prior to biopsy. JAMA 2004 292 : 2735 2742.
28. Morakkabati-Spitz N, Leutner C, Schild H, Traeber F, Kuhl C. Diagnostic usefulness of segmental and linear enhancement in dynamic breast MRI. Eur Radiol 2005 15 : 2010 2017.
29. Mariano MN, van den Bosch MA, Daniel BL et al. Contrast-enhanced MRI of ductal carcinoma in situ: characteristics of a new intensity-modulated parametric mapping technique correlated with histopathologic findings. J Magn Reson Imaging 2005 22 : 520 526.
30. Groves AM, Warren RM, Godward S, Rajan PS. Characterization of pure high-grade DCIS on magnetic resonance imaging using the evolving breast MR lexicon terminology: can it be differentiated from pure invasive disease? Magn Reson Imaging 2005 23 : 733 738.
31. Menell JH, Morris EA, Dershaw DD, Abramson AF, Brogi E, Liberman L. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J 2005 11 : 382 390.
32. Van Goethem M, Schelfout K, Kersschot E et al. Comparison of MRI features of different grades of DCIS and invasive carcinoma of the breast. JBR-BTR 2005 88 : 225 232.
33. Esserman LJ, Kumar AS, Herrera AF et al. Magnetic resonance imaging captures the biology of ductal carcinoma in situ. J Clin Oncol 2006 24 : 4603 4610.
34. Schouten van der Velden AP, Boetes C, Bult P, Wobbes T. The value of magnetic resonance imaging in diagnosis and size assessment of in situ and small invasive breast carcinoma. Am J Surg 2006 192 : 172 178.
35. Kim DY, Moon WK, Cho N et al. MRI of the breast for the detection and assessment of the size of ductal carcinoma in situ. Korean J Radiol 2007 8 : 32 39.
36. Kanemaki Y, Kurihara Y, Okamoto K et al. Ductal carcinoma in situ: correlations between high-resolution magnetic resonance imaging and histopathology. Radiat Med 2007 25 : 1 7.
37. Lehman CD, Gatsonis C, Kuhl CK et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007 356 : 1295 1303.
38. Uematsu T, Yuen S, Kasami M, Uchida Y. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value? Breast Cancer Res Treat 2007 103 : 269 281.
39. Kuhl CK, Schrading S, Bieling HB et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet 2007 370 : 485 492.
40. Santamaria G, Velasco M, Farrus B, Zanon G, Fernandez PL. Preoperative MRI of pure intraductal breast carcinoma - a valuable adjunct to mammography in assessing cancer extent. Breast 2008 17 : 186 194.
41. Rosen EL, Smith-Foley SA, DeMartini WB, Eby PR, Peacock S, Lehman CD. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ. Breast J 2007 13 : 545 550.
42. Facius M, Renz DM, Neubauer H et al. Characteristics of ductal carcinoma in situ in magnetic resonance imaging. Clin Imaging 2007 31 : 394 400.
43. Jansen SA, Newstead GM, Abe H, Shimauchi A, Schmidt RA, Karczmar GS. Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade. Radiology 2007 245 : 684 691.
44. Brown LF, Guidi AJ, Schnitt SJ et al. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res 1999 5 : 1041 1056.
45. Guidi AJ, Schnitt SJ, Fischer L et al. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast. Cancer 1997 80 : 1945 1953.
46. Gupta SK, Douglas-Jones AG, Fenn N, Morgan JM, Mansel RE. The clinical behavior of breast carcinoma is probably determined at the preinvasive stage (ductal carcinoma in situ). Cancer 1997 80 : 1740 1745.
47. Viehweg P, Lampe D, Buchmann J, Heywang-Kobrunner SH. In situ and minimally invasive breast cancer: morphologic and kinetic features on contrast-enhanced MR imaging. MAGMA 2000 11 : 129 137.
48. Heffelfinger SC, Miller MA, Yassin R, Gear R. Angiogenic growth factors in preinvasive breast disease. Clin Cancer Res 1999 5 : 2867 2876.